Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 20.050\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) COc1cccc(-n2c(SCC(=O)N3CCc4ccccc43)nnc2-c2c[nH]c3ccccc23)c1
(b) CCC/C(=C1/c2ccccc2C(=O)N1c1ccccc1)c1ccc2c(c1)OCO2
Answer: b. CCC/C(=C1/c2ccccc2C(=O)N1c1ccccc1)c1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC/C(=C1/c2ccccc2C(=O)N1c1ccccc1)c1ccc2c(c1)OCO2
CCC/C(=C1/c2ccccc2C(=O)N1c1ccccc1)c1ccc2c(c1)OCO2
(3E)-3-[1-(1,3-benzodioxol-5-yl)butylidene]-2-phenylisoindol-1-one